Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago. These figures

Corebridge Financial Q2 Earnings Call Highlights
Corebridge Financial Q2 Earnings Call Highlights

Key Points

Somnigroup International (SGI) Matches Q2 Earnings Estimates
Somnigroup International (SGI) Matches Q2 Earnings Estimates

Somnigroup International (SGI) came out with quarterly earnings of $0.58 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.53 per share a year ago. These figures

Playtika Holding (PLTK) Q2 Earnings Match Estimates
Playtika Holding (PLTK) Q2 Earnings Match Estimates

Playtika Holding (PLTK) came out with quarterly earnings of $0.15 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are

Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $0.8 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.99 per share a year ago. These figures

Krispy Kreme (DNUT) Reports Q2 Loss, Beats Revenue Estimates
Krispy Kreme (DNUT) Reports Q2 Loss, Beats Revenue Estimates

Krispy Kreme (DNUT) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.15 per share a year ago. These figures are adjusted for

Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates
Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates

Aspen Aerogels (ASPN) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago. These figures are adjusted

Watts Water Q2 Earnings Beat Estimates on Data Center Demand
Watts Water Q2 Earnings Beat Estimates on Data Center Demand

Watts Water Technologies, Inc. WTS reported second-quarter 2026 adjusted earnings of $3.66 per share, up 18.4% from $3.09 a year ago. The bottom line beat the Zacks Consensus Estimate of $3.34 by

EBAY Q2 Earnings Beat Estimates on Higher GMV and Ad Growth
EBAY Q2 Earnings Beat Estimates on Higher GMV and Ad Growth

eBay EBAY reported second-quarter 2026 non-GAAP earnings of $1.6 per share, which beat the Zacks Consensus Estimate of $1.51 by 5.96%. The bottom line increased 16.8% year over year.Net revenues of

Starwood Property Trust (STWD) Q2 Earnings Meet Estimates
Starwood Property Trust (STWD) Q2 Earnings Meet Estimates

Starwood Property Trust (STWD) came out with quarterly earnings of $0.4 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.43 per share a year ago. These figures

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Misses Revenue Estimates
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.24 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.41 per share a year ago. These figures are

Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates

Nuvation Bio Inc. (NUVB) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.17 per share a year ago. These figures are

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Roivant Sciences Ltd. (ROIV) came out with a quarterly loss of $0.33 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.18 per share a year ago. These figures are

Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates

Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago. These figures are

FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates
FrontView REIT, Inc. (FVR) Q2 FFO Meet Estimates

FrontView REIT, Inc. (FVR) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.32 per share a year ago

Paycom's Q2 Earnings Surpass Expectations, Revenues Rise Y/YPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7835e381-fcae-4834-ba93-4708292dc055.png
Paycom's Q2 Earnings Surpass Expectations, Revenues Rise Y/Y

Paycom Software, Inc. PAYC reported better-than-expected second-quarter 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate.

The online payroll and human resource

Ormat Technologies Q2 Earnings and Revenues Beat Estimates
Ormat Technologies Q2 Earnings and Revenues Beat Estimates

Ormat Technologies Inc. ORA reported second-quarter 2026 adjusted earnings per share of 50 cents, which beat the Zacks Consensus Estimate of 29 cents by 72.4%. The bottom line also increased 4.2%

Why Delta Air Lines (DAL) is a Top Value Stock for the Long-Term
Why Delta Air Lines (DAL) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

SNEX Q3 Earnings Top on Commercial and Institutional Gains, Stock Dips
SNEX Q3 Earnings Top on Commercial and Institutional Gains, Stock Dips

StoneX Group Inc. (SNEX reported third-quarter fiscal 2026 earnings of $1.00 per share, which handily surpassed the Zacks Consensus Estimate of 76 cents. The bottom line jumped 85.2% year over

United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark

United Therapeutics UTHR reported second-quarter 2026 earnings per share (EPS) of $7.27, beating the Zacks Consensus Estimate of $6.82. Bottom line increased 13.4% year over year.

United